204 related articles for article (PubMed ID: 9161800)
1. Adjuvant therapy for melanoma.
Sondak VK; Wolfe JA
Curr Opin Oncol; 1997 Mar; 9(2):189-204. PubMed ID: 9161800
[TBL] [Abstract][Full Text] [Related]
2. The role of adjuvant therapy in melanoma management.
Barth A; Morton DL
Cancer; 1995 Jan; 75(2 Suppl):726-34. PubMed ID: 7805001
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy of cutaneous malignant melanoma: a critical review.
Koh HK; Sober AJ; Harmon DC; Lew RA; Carey RW
Med Pediatr Oncol; 1985; 13(5):244-60. PubMed ID: 3897817
[TBL] [Abstract][Full Text] [Related]
4. Surgical adjuvant therapy for malignant melanoma.
Pinsky CM; Oettgen HF
Surg Clin North Am; 1981 Dec; 61(6):1259-66. PubMed ID: 7031933
[No Abstract] [Full Text] [Related]
5. Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma.
Verma S; Quirt I; McCready D; Bak K; Charette M; Iscoe N
Cancer; 2006 Apr; 106(7):1431-42. PubMed ID: 16511841
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant therapy of malignant melanoma].
Franke W; Neumann NJ; Ruzicka T; Schulte KW
Praxis (Bern 1994); 2001 Feb; 90(8):301-6. PubMed ID: 11256332
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy for malignant melanoma.
Kaiser LR; Burk MW; Morton DL
Surg Clin North Am; 1981 Dec; 61(6):1249-57. PubMed ID: 7313933
[No Abstract] [Full Text] [Related]
8. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the care of the patient with malignant melanoma.
Reintgen D; Balch CM; Kirkwood J; Ross M
Ann Surg; 1997 Jan; 225(1):1-14. PubMed ID: 8998115
[TBL] [Abstract][Full Text] [Related]
10. Melanoma adjuvant therapy.
Tarhini AA; Thalanayar PM
Hematol Oncol Clin North Am; 2014 Jun; 28(3):471-89. PubMed ID: 24880942
[TBL] [Abstract][Full Text] [Related]
11. The use of interferon-alpha in the treatment of cutaneous melanoma: a review.
Punt CJ
Melanoma Res; 1998 Apr; 8(2):95-104. PubMed ID: 9610861
[TBL] [Abstract][Full Text] [Related]
12. Results of adjuvant BCG immunotherapy in malignant melanoma.
Wätzig V; Knopf B
Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
[TBL] [Abstract][Full Text] [Related]
14. The adjuvant treatment of malignant melanoma.
Reintgen D; Kirkwood J
J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant immunotherapy with BCG in stage II malignant melanoma.
Byrne MJ; Van Hazel G; Reynolds PM; Lemish WM; Holman CD
J Surg Oncol; 1983 Jun; 23(2):114-6. PubMed ID: 6343725
[TBL] [Abstract][Full Text] [Related]
16. Advances in melanoma therapy.
Johnson TM; Yahanda AM; Chang AE; Fader DJ; Sondak VK
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):731-41. PubMed ID: 9591818
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy in melanoma.
Mohr P; Weichenthal M; Hauschild A
Onkologie; 2003 Jun; 26(3):227-33. PubMed ID: 12845206
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant immunotherapy.
Goodnight JE; Morton DL
Int Adv Surg Oncol; 1978; 1():53-83. PubMed ID: 399764
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
[TBL] [Abstract][Full Text] [Related]
20. BCG immunotherapy as a systemic adjunct to surgery in malignant melanoma.
Morton DL; Eilber FR; Holmes EC; Sparks FC; Ramming K
Med Clin North Am; 1976 May; 60(3):431-9. PubMed ID: 1271888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]